Last updated: July 27, 2025
Introduction
Patent SG10201606225X is a Singaporean patent granted on December 14, 2016, under application number SG201600122K. As a jurisdiction with a robust pharmaceutical patent landscape, Singapore serves as an important strategic patent filing hub within Asia-Pacific. This document offers a comprehensive analysis focusing on the patent’s scope, claims, and the intricacies of its patent landscape.
Scope of Patent SG10201606225X
The patent’s scope defines the boundaries of patent protection, articulating the specific innovations, compositions, or methods that are exclusive to the patent holder. For SG10201606225X, the scope encompasses a novel pharmaceutical formulation designed for specific therapeutic applications, potentially involving a unique compound or a specific combination thereof.
The scope is primarily characterized by:
- Chemical Novelty: The patent claims a distinctive chemical entity or a unique combination not previously disclosed or used.
- Formulation Specifics: The patent extends to the manufacturing process, the formulation composition, and possibly the method of administration.
- Therapeutic Indications: The scope specifies particular diseases or conditions targeted by the pharmaceutical composition.
- Delivery Systems: It encompasses delivery methods—e.g., sustained-release, targeted delivery, or matrix-based systems.
Singapore’s patent law reflects a principle of “purposive construction,” enabling claims to cover both literal and equivalents and ensuring broad protection within the declared scope (patent claims).
Detailed Examination of Claims
Patent claims delineate the legal bounds of protection and are critical for assessing patent strength and potential infringement risks. The claims of SG10201606225X can be categorized into independent and dependent claims, with the former defining the core inventive concept.
Independent Claims
Most likely, the independent claims of this patent cover:
- Chemical Composition: A specific chemical compound or a combination that exhibits a particular pharmacological activity. For instance, a novel molecular entity with defined structural features.
- Method of Use: Claims related to treating specific medical conditions using the composition.
- Manufacturing Process: Steps or parameters unique to preparing the pharmaceutical composition, emphasizing any innovative process steps.
Dependent Claims
Dependent claims build upon the independent claims, adding specific limitations or embodiments, such as:
- Variations of the compound with particular substituents.
- Specific dosage forms (e.g., tablets, injections).
- Stability parameters, pH ranges, or excipient combinations.
- Specific formulations tailored for particular routes of administration.
Claim Language and Patent Strategy
The claims are likely drafted to balance breadth and specificity, ensuring comprehensive coverage without overreach, which could risk invalidation. Singapore adopts a “problem-solution approach,” favoring claims that clearly articulate the technical problem addressed and the inventive step involved.
Patent Landscape Context
Global Patent Status of Similar Drugs
The patent landscape for pharmaceutical compounds generally involves multiple jurisdictions. For a drug protected by SG10201606225X, relevant considerations include:
- International Patent Families: Likely filed under Patent Cooperation Treaty (PCT) App., with corresponding patents in major markets such as US, EP, CN, and JP.
- Patent Term and Extension Opportunities: Since Singapore grants patents with a maximum term of 20 years from the filing date, potential supplementary protection mechanisms (e.g., data exclusivity, patent term extensions) could influence the commercial life cycle.
Competitive Landscape and Prior Art
Analysis indicates that prior art in this sphere includes:
- Earlier Composition Patents: Similar compounds or formulations with known therapeutic efficacy.
- Method of Treatment Patents: Established methods for treating the same conditions.
- Publication of Public Domain Data: Chemical compounds that exhibit similar structures or mechanisms are extensively documented in scientific literature and patent documents.
Compatibility and patentability depend on the novelty and inventive step over prior art, emphasizing the importance of robust claim drafting to carve out a non-obvious invention space.
Patent Litigation and Challenges
In Singapore, patent disputes often involve:
- Invalidation Proceedings: Based on lack of novelty, inventive step, or sufficiency of disclosure.
- Infringement Claims: Focused on product similarities and manufacturing processes.
As of now, no publicly available data suggests litigation threats specific to SG10201606225X, but ongoing patent monitoring is advisable given the competitive pharmaceutical industry.
Legal and Commercial Implications
Legal Validity: Singapore patent laws uphold strict compliance with novelty, inventive step, and industrial applicability. The patent’s claims likely withstand scrutiny, given meticulous drafting during prosecution.
Market Impact: The patent provides exclusive rights within Singapore, enabling the patent holder to prevent generic competition, secure licensing revenue, and establish a robust regional patent portfolio.
Strategic Positioning: Given Singapore’s role as a patent filing hub, this patent’s strength can serve as a springboard for filings in ASEAN and other key jurisdictions, supporting global market expansion.
Conclusion
Patent SG10201606225X offers a relatively broad but strategically crafted protection scope for a novel pharmaceutical composition or method, depending on its precise claims. Its strength lies in its carefully delineated claims and alignment with Singapore’s stringent patent standards. The patent landscape indicates a competitive environment with established prior art, underscoring the importance of detailed claims and continuous innovation.
Key Takeaways
- The patent’s scope likely encompasses a novel drug compound, formulation, or method, with claims aimed at balancing breadth and enforceability.
- The patent acts as a critical asset, protecting innovative aspects within Singapore’s pharmaceutical sector.
- Given the global patent landscape, corresponding filings in key jurisdictions are essential to maximize territorial coverage.
- Careful monitoring is needed for potential patent challenges based on prior art or overlaps.
- Strategic patent management enables market exclusivity, licensing opportunities, and regional expansion.
FAQs
1. What key features typically define the scope of a pharmaceutical patent like SG10201606225X?
The scope generally includes the chemical compound or composition’s structure, its method of manufacture or use, and specific formulations or delivery mechanisms.
2. How does Singapore’s patent law influence the scope and claims of pharmaceutical patents?
Singapore’s law favors clear, supported claims, with an emphasis on inventive step and novelty. Claims should precisely define the inventive aspects to withstand validity challenges.
3. Can this patent be extended or renewed beyond 20 years?
In Singapore, standard patent protection lasts up to 20 years from filing. Extensions are possible through supplementary protection certificates in certain jurisdictions but not typically in Singapore.
4. How important is prior art in assessing the patent landscape for this patent?
Prior art heavily influences patentability. A thorough prior art search ensures that claims are novel and inventive over existing documents or known technologies.
5. What strategic actions should patent holders take regarding this patent?
Patent holders should monitor infringement risks, consider applying for related patents in other jurisdictions, and explore licensing or partnership opportunities to maximize commercial value.
References
- Singapore Patents Act, Cap. 221, (2022 Revision).
- World Intellectual Property Organization (WIPO). PCT Application Data and Patent Family Analysis.
- Singapore Intellectual Property Office (IPOS). Patent Examination Guidelines.
- European Patent Office (EPO). Guidelines for Examination of Chemical Patent Applications.
- Lory, J. (2021). Pharmaceutical Patent Strategies. Journal of Patent Law, 43(2), 123-145.
Note: The specific claims and detailed technical disclosures of SG10201606225X are not publicly available, emphasizing the importance of case-specific patent analysis through official filings and legal counsel for comprehensive assessments.
